Home
>
National Drug Code (NDC)
>
CRIXIVAN
CRIXIVAN - 16590-064-90 - (INDINAVIR SULFATE)
Drug Information of CRIXIVAN
| Product NDC: | 16590-064 |
| Proprietary Name: | CRIXIVAN |
| Non Proprietary Name: | INDINAVIR SULFATE |
| Active Ingredient(s): | 400 mg/1 & nbsp; INDINAVIR SULFATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CRIXIVAN
| Product NDC: | 16590-064 |
| Labeler Name: | STAT Rx USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020685 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960313 |
Package Information of CRIXIVAN
| Package NDC: | 16590-064-90 |
| Package Description: | 90 CAPSULE in 1 BOTTLE (16590-064-90) |
NDC Information of CRIXIVAN
| NDC Code | 16590-064-90 |
| Proprietary Name | CRIXIVAN |
| Package Description | 90 CAPSULE in 1 BOTTLE (16590-064-90) |
| Product NDC | 16590-064 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | INDINAVIR SULFATE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19960313 |
| Marketing Category Name | NDA |
| Labeler Name | STAT Rx USA LLC |
| Substance Name | INDINAVIR SULFATE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |
